Science Funding Criteria Challenged

Republican representatives question how the NSF reviews grants.

Written byKate Yandell
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

The President's science advisor John HoldrenNASA, PAUL E. ALERSAt a hearing held by the Committee on Science, Space and Technology earlier this week (April 17), congressmen and women discussed how the National Science Foundation (NSF) should spend its money, saying that the agency should focus on more practical research, ScienceInsider reported.

Committee leader Lamar Smith, a Republican representative from Texas, suggested that the NSF should ask those applying for grants to demonstrate how their research would benefit American citizens.

National Science Board Chair Dan Arvizu, who was at the hearing representing the NSF with the agency’s acting director, Cora Marrett, retorted that the agency already assesses intellectual merit and broader impacts of research and that applying Smith’s criteria could “compromise the integrity of the process.” “Are you saying that requiring the research to benefit Americans would be limiting?” said Smith, according to ScienceInsider.

Earlier in the day, the legislators had grilled White House science advisor John Holdren, zeroing in on social science projects they did not believe should have been funded, such as a study of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies